932 related articles for article (PubMed ID: 31499007)
1. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
Zeuschner P; Linxweiler J; Junker K
Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
[No Abstract] [Full Text] [Related]
2. Liquid biopsies in urological cancers: what we need to know before starting using them.
Franceschini T; Giunchi F; Montironi R; Scarpelli M; Lopez-Beltran A; Cheng L; Fiorentino M
Expert Rev Mol Diagn; 2020 Feb; 20(2):135-139. PubMed ID: 31509027
[No Abstract] [Full Text] [Related]
3. Epigenetic biomarkers in the blood of patients with urological malignancies.
Ellinger J; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2015 Apr; 15(4):505-16. PubMed ID: 25719388
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of non-coding circulating RNA as a biomarker in renal cell carcinoma.
Ellinger J; Gevensleben H; Müller SC; Dietrich D
Expert Rev Mol Diagn; 2016 Oct; 16(10):1059-1065. PubMed ID: 27649770
[TBL] [Abstract][Full Text] [Related]
5. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications.
Reese M; Dhayat SA
J Hematol Oncol; 2021 Sep; 14(1):141. PubMed ID: 34496946
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
[No Abstract] [Full Text] [Related]
7. Extracellular Vesicles and Their Role in Urologic Malignancies.
Junker K; Heinzelmann J; Beckham C; Ochiya T; Jenster G
Eur Urol; 2016 Aug; 70(2):323-31. PubMed ID: 26924769
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles in urological malignancies: an update.
Linxweiler J; Junker K
Nat Rev Urol; 2020 Jan; 17(1):11-27. PubMed ID: 31827264
[TBL] [Abstract][Full Text] [Related]
9. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
Lopez-Beltran A; Cheng L; Gevaert T; Blanca A; Cimadamore A; Santoni M; Massari F; Scarpelli M; Raspollini MR; Montironi R
Expert Rev Mol Diagn; 2020 Feb; 20(2):231-243. PubMed ID: 31795775
[No Abstract] [Full Text] [Related]
10. Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology.
Hu W; Liu C; Bi ZY; Zhou Q; Zhang H; Li LL; Zhang J; Zhu W; Song YY; Zhang F; Yang HM; Bi YY; He QQ; Tan GJ; Sun CC; Li DJ
Mol Cancer; 2020 Jun; 19(1):102. PubMed ID: 32503543
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsy in germ cell tumors: biology and clinical management.
Chovanec M; Kalavska K; Mego M; Cheng L
Expert Rev Mol Diagn; 2020 Feb; 20(2):187-194. PubMed ID: 31652083
[No Abstract] [Full Text] [Related]
12. Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
Kouba E; Lopez-Beltran A; Montironi R; Massari F; Huang K; Santoni M; Chovanec M; Cheng M; Scarpelli M; Zhang J; Cimadamore A; Cheng L
Expert Rev Mol Diagn; 2020 Feb; 20(2):255-264. PubMed ID: 31608720
[No Abstract] [Full Text] [Related]
13. Exosomal microRNAs and other non-coding RNAs as colorectal cancer biomarkers: a review.
Francavilla A; Turoczi S; Tarallo S; Vodicka P; Pardini B; Naccarati A
Mutagenesis; 2020 Jul; 35(3):243-260. PubMed ID: 31784760
[TBL] [Abstract][Full Text] [Related]
14. How can biomarkers assist the prognosis of urologic malignancies?
Falzarano SM; Feely MM
Expert Rev Mol Diagn; 2020 Feb; 20(2):131-133. PubMed ID: 31495243
[No Abstract] [Full Text] [Related]
15. Extracellular vesicles: Toward a clinical application in urological cancer treatment.
Urabe F; Kosaka N; Kimura T; Egawa S; Ochiya T
Int J Urol; 2018 Jun; 25(6):533-543. PubMed ID: 29726046
[TBL] [Abstract][Full Text] [Related]
16. Circulating non-coding RNAs in chronic kidney disease and its complications.
van Zonneveld AJ; Zhao Q; Rotmans JI; Bijkerk R
Nat Rev Nephrol; 2023 Sep; 19(9):573-586. PubMed ID: 37286733
[TBL] [Abstract][Full Text] [Related]
17. Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights.
Hosseinalizadeh H; Mahmoodpour M; Ebrahimi A
Mol Biol Rep; 2022 Jan; 49(1):705-715. PubMed ID: 34677714
[TBL] [Abstract][Full Text] [Related]
18. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
19. Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential.
Beňačka R; Szabóová D; Guľašová Z; Hertelyová Z; Radoňak J
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003403
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer and the Other Non-Coding RNAs.
Dvorská D; Braný D; Ňachajová M; Halašová E; Danková Z
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33807045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
